Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
Citigroup stock (NYSE: C) fell on mixed Q4 results, with divestiture losses and rising expenses overshadowing strong revenue.
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback